SOFI Directional Report
Analysis based on market close March 31, 2026
Outlook
Neutral-to-bearish with a weak upward magnet to $16-$17 (max pain). Confidence: 4/10. Negative GEX (-$9.6M) and bullish net flow ($112K) conflict, but spot remains 9.2% below nearest max pain, suggesting pinning pressure is weak. High IV (76.2%) and a trending gamma regime favor defined-risk strategies.
Conflicts: Negative GEX (-$9.6M) vs bullish flow; Spot far below MP reduces pin efficacy.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-9.6M
DEX: +121.1M shares
Gamma flip: ~$15 (Approx โ based on put OI concentration of 71,224)
NTM gamma: Dealers net short gamma. A move below $15 triggers accelerated selling as they delta-hedge short puts. A move above $16 sees less aggressive buying due to long call exposure from sold calls.
IV Analysis
IV vs VIX: IV 76.2% is extremely rich, offering high nominal edge to premium sellers but paired with high single-stock risk.
Term structure: Humped: 5/01 expiry peaks at 72.4% vs ~63% for April, suggesting earnings anticipation (4/28). Near-term (4/02) IV at 61.1% is relatively lower.
Skew: Near-term (4/02) IV ~11 vol points cheaper than 5/01 โ supports a reverse calendar (sell May, buy April) for vol differential harvest.
Flow Analysis
Net premium: +$112K bullish; P/C vol 0.45 shows heavy call volume dominance.
Directional prints: $17C 4/10 vol 17,431 vs OI 5,359 (3.2x) at IV 57.8% โ likely bought calls targeting max pain. $15.50C 4/17 vol 9,319 vs OI 2,775 (3.4x) โ likely bought calls near spot.
Unusual: $9C 4/02 vol 149 at IV 318.8% โ deep ITM call with massive IV, likely a complex financing or collar trade, not a directional signal.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long Stock | Weak | Buy shares at $15.50 | Negative GEX amplifies downturns; defined risk strategies offer better R/R. |
| Short Stock | Moderate | Short shares at $15.50, stop above $16.50 | Weak pin to $17 and bullish flow shift; better expressed via puts. |
| Covered Call | Moderate-Strong | Buy stock at $15.50, sell 4/17 $18 Call (~$0.25 credit) | Full downside exposure remains; best for existing shareholders wanting yield against call walls. |
| Cash-Secured Put / Put Spread | Moderate-Strong | Sell 5/01 $15 Put (~$1.50 credit) or $15/$14 Put Spread 4/17 | Assignment at $15; spread defines risk below key support. High IV provides rich premium. |
| Long Calls | Weak | Avoid due to extreme IV, negative GEX, and distant max pain. | IV crush and time decay are severe; pin to $17 caps upside. |
| Long Puts / Bear Put Spread | Moderate | Buy 4/17 $16 Put, sell $15 Put for ~$0.45 debit (bear put spread) | Bullish flow shift conflicts; defined risk below $15.55 breakeven. |
| Iron Condor | Moderate-Weak | $14/$14.50P x $16.50/$17C 4/17 (outside EM bounds) | Negative GEX makes range breaks more likely; wings must be very wide. VIX not a factor given GEX negative. |
| Calendar/Diagonal | Moderate-Strong | Sell 5/01 $17 Call (IV 72.4%), buy 4/17 $16 Call (IV 63.7%) for a ~$0.15 credit (reverse calendar). | Requires spot to stay between $16-$17 through April expiry; exploits IV differential. |
| PMCC / LEAPS Diagonal | Moderate | Buy Jan 2027 $15 Call (~$5.00), sell monthly ~$1-2 OTM calls against it. | High capital outlay; long-dated IV still elevated at ~68%. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for SOFI for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.